{"entity":{"type":"insider","cik":"0001916664","url":"/insider/0001916664","json_url":"/insider/0001916664.json","name":"Owens David","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":11,"first":"2022-09-20","last":"2025-02-05","span_basis":"filed_date"},"name_variants":[{"name":"Owens David","source":"filing","n_filings":11,"first_seen":"2022-09-20","last_seen":"2025-02-05"}],"transactions":[{"id":4855826,"accession":"0001829126-25-000672","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001829126-25-000672","line_url":"/filing/0001829126-25-000672#line-1","is_derivative":false,"issuer_cik":"0001527352","issuer_name":"Nexalin Technology, Inc.","issuer_ticker":"NXL","issuer_name_source":null,"issuer_url":"/issuer/0001527352","owner_cik":"0001916664","owner_name":"Owens David","owner_display_name":"Owens David","owner_url":"/insider/0001916664","role":"Director, Officer (Chief Medical Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":2.98,"price_display":"2.98","price_state":"stated","total_value":2980.0,"total_display":"2,980.00","total_whole":"2,980","shares_owned_after":154793.0,"shares_owned_after_display":"154,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-04","filed_date":"2025-02-04","scope":"insider"},{"id":4077185,"accession":"0001829126-25-000724","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001829126-25-000724","line_url":"/filing/0001829126-25-000724#line-1","is_derivative":false,"issuer_cik":"0001527352","issuer_name":"Nexalin Technology, Inc.","issuer_ticker":"NXL","issuer_name_source":null,"issuer_url":"/issuer/0001527352","owner_cik":"0001916664","owner_name":"Owens David","owner_display_name":"Owens David","owner_url":"/insider/0001916664","role":"Director, Officer (Chief Medical Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":3.1,"price_display":"3.10","price_state":"stated","total_value":3100.0,"total_display":"3,100.00","total_whole":"3,100","shares_owned_after":155793.0,"shares_owned_after_display":"155,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-04","filed_date":"2025-02-05","scope":"insider"},{"id":4482870,"accession":"0001829126-25-000542","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001829126-25-000542","line_url":"/filing/0001829126-25-000542#line-1","is_derivative":false,"issuer_cik":"0001527352","issuer_name":"Nexalin Technology, Inc.","issuer_ticker":"NXL","issuer_name_source":null,"issuer_url":"/issuer/0001527352","owner_cik":"0001916664","owner_name":"Owens David","owner_display_name":"Owens David","owner_url":"/insider/0001916664","role":"Director, Officer (Chief Medical Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":2.7,"price_display":"2.70","price_state":"stated","total_value":4050.0,"total_display":"4,050.00","total_whole":"4,050","shares_owned_after":153793.0,"shares_owned_after_display":"153,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-28","filed_date":"2025-01-29","scope":"insider"},{"id":5134110,"accession":"0001829126-25-000368","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001829126-25-000368","line_url":"/filing/0001829126-25-000368#line-2","is_derivative":false,"issuer_cik":"0001527352","issuer_name":"Nexalin Technology, Inc.","issuer_ticker":"NXL","issuer_name_source":null,"issuer_url":"/issuer/0001527352","owner_cik":"0001916664","owner_name":"Owens David","owner_display_name":"Owens David","owner_url":"/insider/0001916664","role":"Director, Officer (Chief Medical Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":2.7,"price_display":"2.70","price_state":"stated","total_value":2700.0,"total_display":"2,700.00","total_whole":"2,700","shares_owned_after":152293.0,"shares_owned_after_display":"152,293","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-23","filed_date":"2025-01-24","scope":"insider"},{"id":5134103,"accession":"0001829126-25-000368","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001829126-25-000368","line_url":"/filing/0001829126-25-000368#line-1","is_derivative":false,"issuer_cik":"0001527352","issuer_name":"Nexalin Technology, Inc.","issuer_ticker":"NXL","issuer_name_source":null,"issuer_url":"/issuer/0001527352","owner_cik":"0001916664","owner_name":"Owens David","owner_display_name":"Owens David","owner_url":"/insider/0001916664","role":"Director, Officer (Chief Medical Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":2.5,"price_display":"2.50","price_state":"stated","total_value":5000.0,"total_display":"5,000.00","total_whole":"5,000","shares_owned_after":151293.0,"shares_owned_after_display":"151,293","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-13","filed_date":"2025-01-24","scope":"insider"},{"id":4898079,"accession":"0001829126-25-000544","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001829126-25-000544","line_url":"/filing/0001829126-25-000544#line-1","is_derivative":false,"issuer_cik":"0001527352","issuer_name":"Nexalin Technology, Inc.","issuer_ticker":"NXL","issuer_name_source":null,"issuer_url":"/issuer/0001527352","owner_cik":"0001916664","owner_name":"Owens David","owner_display_name":"Owens David","owner_url":"/insider/0001916664","role":"Director, Officer (Chief Medical Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":2.75,"price_display":"2.75","price_state":"stated","total_value":2750.0,"total_display":"2,750.00","total_whole":"2,750","shares_owned_after":149293.0,"shares_owned_after_display":"149,293","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-20","filed_date":"2025-01-29","scope":"insider"},{"id":2804027,"accession":"0001829126-24-007091","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001829126-24-007091","line_url":"/filing/0001829126-24-007091#line-1","is_derivative":false,"issuer_cik":"0001527352","issuer_name":"Nexalin Technology, Inc.","issuer_ticker":"NXL","issuer_name_source":null,"issuer_url":"/issuer/0001527352","owner_cik":"0001916664","owner_name":"Owens David","owner_display_name":"Owens David","owner_url":"/insider/0001916664","role":"Director, Officer (Chief Medical Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":2.19,"price_display":"2.19","price_state":"stated","total_value":1095.0,"total_display":"1,095.00","total_whole":"1,095","shares_owned_after":148293.0,"shares_owned_after_display":"148,293","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-28","filed_date":"2024-10-30","scope":"insider"},{"id":2573679,"accession":"0001829126-24-005573","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001829126-24-005573","line_url":"/filing/0001829126-24-005573#line-1","is_derivative":false,"issuer_cik":"0001527352","issuer_name":"Nexalin Technology, Inc.","issuer_ticker":"NXL","issuer_name_source":null,"issuer_url":"/issuer/0001527352","owner_cik":"0001916664","owner_name":"Owens David","owner_display_name":"Owens David","owner_url":"/insider/0001916664","role":"Director, Officer (Chief Medical Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.95,"price_display":"0.95","price_state":"stated","total_value":950.0,"total_display":"950.00","total_whole":"950","shares_owned_after":147793.0,"shares_owned_after_display":"147,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-13","filed_date":"2024-08-15","scope":"insider"},{"id":2714453,"accession":"0001829126-24-004517","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001829126-24-004517","line_url":"/filing/0001829126-24-004517#line-1","is_derivative":false,"issuer_cik":"0001527352","issuer_name":"Nexalin Technology, Inc.","issuer_ticker":"NXL","issuer_name_source":null,"issuer_url":"/issuer/0001527352","owner_cik":"0001916664","owner_name":"Owens David","owner_display_name":"Owens David","owner_url":"/insider/0001916664","role":"Director, Officer (Chief Medical Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":1.75,"price_display":"1.75","price_state":"stated","total_value":1750.0,"total_display":"1,750.00","total_whole":"1,750","shares_owned_after":146793.0,"shares_owned_after_display":"146,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-28","filed_date":"2024-07-01","scope":"insider"},{"id":3009020,"accession":"0001829126-24-004353","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001829126-24-004353","line_url":"/filing/0001829126-24-004353#line-1","is_derivative":false,"issuer_cik":"0001527352","issuer_name":"Nexalin Technology, Inc.","issuer_ticker":"NXL","issuer_name_source":null,"issuer_url":"/issuer/0001527352","owner_cik":"0001916664","owner_name":"Owens David","owner_display_name":"Owens David","owner_url":"/insider/0001916664","role":"Director, Officer (Chief Medical Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1619.0,"shares_display":"1,619","price_per_share":0.71,"price_display":"0.71","price_state":"stated","total_value":1149.49,"total_display":"1,149.49","total_whole":"1,149","shares_owned_after":145793.0,"shares_owned_after_display":"145,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-18","filed_date":"2024-06-21","scope":"insider"},{"id":2524277,"accession":"0001829126-24-004108","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001829126-24-004108","line_url":"/filing/0001829126-24-004108","is_derivative":false,"issuer_cik":"0001527352","issuer_name":"Nexalin Technology, Inc.","issuer_ticker":"NXL","issuer_name_source":null,"issuer_url":"/issuer/0001527352","owner_cik":"0001916664","owner_name":"Owens David","owner_display_name":"Owens David","owner_url":"/insider/0001916664","role":"Director, Officer (Chief Medical Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":0.64,"price_display":"0.64","price_state":"stated","total_value":1920.0,"total_display":"1,920.00","total_whole":"1,920","shares_owned_after":143174.0,"shares_owned_after_display":"143,174","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-10","filed_date":"2024-06-12","scope":"insider","n_lines":2},{"id":6410750,"accession":"0001829126-22-017005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001829126-22-017005","line_url":"/filing/0001829126-22-017005#line-1","is_derivative":false,"issuer_cik":"0001527352","issuer_name":"Nexalin Technology, Inc.","issuer_ticker":"NXL","issuer_name_source":null,"issuer_url":"/issuer/0001527352","owner_cik":"0001916664","owner_name":"Owens David","owner_display_name":"Owens David","owner_url":"/insider/0001916664","role":"Director, Officer (Chief Medical Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":4.15,"price_display":"4.15","price_state":"stated","total_value":10375.0,"total_display":"10,375.00","total_whole":"10,375","shares_owned_after":141174.0,"shares_owned_after_display":"141,174","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-16","filed_date":"2022-09-20","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":13,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001527352","name":"Nexalin Technology, Inc.","url":"/issuer/0001527352","role":"Director, Officer (Chief Medical Officer)","n_filings":11,"first_seen":"2022-09-20","last_seen":"2025-02-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001916664","retrieved_at":"2026-08-24T22:23:06+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}